Targeted deletion of RasGRP1 impairs skin tumorigenesis

Carcinogenesis

Volumn 35, Issue 5, 2014, Pages 1084-1091

  Sharma, Amrish ^a,b   Fonseca, Lauren L ^a,c   Rajani, Cynthia ^a   Yanagida, Jodi K ^a   Endo, Yuka ^a   Cline, J Mark ^d   Stone, James C ^e   Ji, Junfang ^a   Ramos, Joe W ^a   Lorenzo, Patricia S ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CODON; CONTROLLED STUDY; DNA FRAGMENTATION; EPIDERMIS; EPIDERMIS HYPERPLASIA; GENE; GENE DELETION; GENE MUTATION; GENOTYPE; HISTOLOGY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RASGRP1 GENE; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; TUMOR PROMOTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CODON; GENE DELETION; GENE TARGETING; GENES, RAS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HYPERPLASIA; MICE; MICE, KNOCKOUT; MUTATION; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTIONAL ACTIVATION;

EID: 84901982123     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu016     Document Type: Article

References (47)

1. Alam, M. et al. (2001) Cutaneous squamous-cell carcinoma. N. Engl. J. Med., 344, 975-983.
2. Madan, V. et al. (2010) Non-melanoma skin cancer. Lancet, 375, 673-685.
3. van der Schroeff, J.G. et al. (1990) Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J. Invest. Dermatol., 94, 423-425.
4. Pierceall, W.E. et al. (1991) Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol. Carcinog., 4, 196-202.
5. Yuspa, S.H. (1998) The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J. Dermatol. Sci., 17, 1-7.
6. DiGiovanni, J. (1992) Multistage carcinogenesis in mouse skin. Pharmacol. Ther., 54, 63-128.
7. Bourne, H.R. et al. (1990) The GTPase superfamily: a conserved switch for diverse cell functions. Nature, 348, 125-132.
8. Macara, I.G. et al. (1996) The Ras superfamily of GTPases. FASEB J., 10, 625-630.
9. Feig, L.A. et al. (1988) Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins. Mol. Cell. Biol., 8, 2472-2478.
10. Juillard, F. et al. (2012) Epstein-Barr virus protein EB2 stimulates cytoplasmic mRNA accumulation by counteracting the deleterious effects of SRp20 on viral mRNAs. Nucleic Acids Res., 40, 6834-6849.
11. Shimizu, T. et al. (2001) Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology, 202, 203-206.
12. Maubec, E. et al. (2005) Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. Anticancer Res., 25, 1205-1210.
13. Toll, A. et al. (2010) Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas. Exp. Dermatol., 19, 151-153.
14. Kiguchi, K. et al. (1995) Elevation of transforming growth factor-alpha mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis. Mol. Carcinog., 12, 225-235.
15. Kiguchi, K. et al. (1998) Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol. Mol. Carcinog., 22, 73-83.
16. Bos, J.L. et al. (2007) GEFs and GAPs: critical elements in the control of small G proteins. Cell, 129, 865-877.
17. Vigil, D. et al. (2010) Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat. Rev. Cancer, 10, 842-857.
18. Rambaratsingh, R.A. et al. (2003) RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes. J. Biol. Chem., 278, 52792-52801.
19. Ebinu, J.O. et al. (1998) RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Science, 280, 1082-1086.
20. Lorenzo, P.S. et al. (2000) The guanine nucleotide exchange factor RasGRP is a high-affinity target for diacylglycerol and phorbol esters. Mol. Pharmacol., 57, 840-846.
21. Oki-Idouchi, C.E. et al. (2007) Transgenic overexpression of RasGRP1 in mouse epidermis results in spontaneous tumors of the skin. Cancer Res., 67, 276-280.
22. Diez, F.R. et al. (2009) RasGRP1 transgenic mice develop cutaneous squamous cell carcinomas in response to skin wounding: potential role of granulocyte colony-stimulating factor. Am. J. Pathol., 175, 392-399.
23. Luke, C.T. et al. (2007) RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis. Cancer Res., 67, 10190-10197.
24. Sharma, A. et al. (2010) RasGRP1 is essential for ras activation by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate in epidermal keratinocytes. J. Biol. Chem., 285, 15724-15730.
25. Dower, N.A. et al. (2000) RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat. Immunol., 1, 317-321.
26. Nelson, M.A. et al. (1992) Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc. Natl Acad. Sci. USA, 89, 6398-6402.
27. Tuthill, M.C. et al. (2006) Differential effects of bryostatin 1 and 12-O-tetradecanoylphorbol-13-acetate on the regulation and activation of RasGRP1 in mouse epidermal keratinocytes. Mol. Cancer Ther., 5, 602-610.
28. Malliri, A. et al. (2002) Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature, 417, 867-871.
29. Sharma, A. et al. (2010) RASGRP1 is essential for ras activation by the tumor promoter 12-o-tetradecanoylphorbol-13-acetate in epidermal keratinocytes. J. Biol. Chem., 285, 15724-15730.
30. Balmain, A. et al. (1983) Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature, 303, 72-74.
31. Quintanilla, M. et al. (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature, 322, 78-80.
32. Bianchi, A.B. et al. (1990) Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. Proc. Natl Acad. Sci. USA, 87, 6902-6906.
33. Imamoto, A. et al. (1991) Evidence for autocrine/paracrine growth stimulation by transforming growth factor-alpha during the process of skin tumor promotion. Mol. Carcinog., 4, 52-60.
34. Chen, N. et al. (2001) Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res., 61, 3908-3912.
35. Slaga, T.J. et al. (1976) Epidermal cell proliferation and promoting ability of phorbol esters. J. Natl Cancer Inst., 57, 1145-1149.
36. Kikkawa, U. et al. (1986) [The role of protein kinase C in cell surface signal transduction and tumor promotion]. Gan To Kagaku Ryoho., 13(3 Pt 2), 861-869.
37. Blumberg, P.M. (1988) Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res., 48, 1-8.
38. Priatel, J.J. et al. (2002) RasGRP1 transduces low-grade TCR signals which are critical for T cell development, homeostasis, and differentiation. Immunity, 17, 617-627.
39. Chen, Y. et al. (2012) Differential requirement of RasGRP1 for gammadelta T cell development and activation. J. Immunol., 189, 61-71.
40. Ilkovitch, D. (2011) Role of immune-regulatory cells in skin pathology. J. Leukoc. Biol., 89, 41-49.
41. Yusuf, N. et al. (2008) Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis. Cancer Res., 68, 3924-3930.
42. Roberts, S.J. et al. (2007) Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis. Proc. Natl Acad. Sci. USA, 104, 6770-6775.
43. Kwong, B.Y. et al. (2010) Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carcinogenesis. J. Invest. Dermatol., 130, 1726-1736.
44. Girardi, M. et al. (2001) Regulation of cutaneous malignancy by gammadelta T cells. Science, 294, 605-609.
45. Girardi, M. et al. (2003) The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer. J. Exp. Med., 198, 747-755.
46. Strid, J. et al. (2008) Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat. Immunol., 9, 146-154.
47. Arwert, E.N. et al. (2010) Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate. Proc. Natl Acad. Sci. USA, 107, 19903-19908.